KR20260018020A - 미로가발린을 함유하는 의약 조성물 - Google Patents

미로가발린을 함유하는 의약 조성물

Info

Publication number
KR20260018020A
KR20260018020A KR1020257037178A KR20257037178A KR20260018020A KR 20260018020 A KR20260018020 A KR 20260018020A KR 1020257037178 A KR1020257037178 A KR 1020257037178A KR 20257037178 A KR20257037178 A KR 20257037178A KR 20260018020 A KR20260018020 A KR 20260018020A
Authority
KR
South Korea
Prior art keywords
mirogabalin
pharmaceutically acceptable
solid
acceptable salt
solid preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257037178A
Other languages
English (en)
Korean (ko)
Inventor
유키 미야노
겐고 고바야시
Original Assignee
다이이찌 산쿄 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이이찌 산쿄 가부시키가이샤 filed Critical 다이이찌 산쿄 가부시키가이샤
Publication of KR20260018020A publication Critical patent/KR20260018020A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
KR1020257037178A 2023-06-02 2024-05-30 미로가발린을 함유하는 의약 조성물 Pending KR20260018020A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2023-091991 2023-06-02
JP2023091991 2023-06-02
PCT/JP2024/019828 WO2024248079A1 (ja) 2023-06-02 2024-05-30 ミロガバリンを含有する医薬組成物

Publications (1)

Publication Number Publication Date
KR20260018020A true KR20260018020A (ko) 2026-02-06

Family

ID=93658131

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257037178A Pending KR20260018020A (ko) 2023-06-02 2024-05-30 미로가발린을 함유하는 의약 조성물

Country Status (5)

Country Link
JP (1) JPWO2024248079A1 (https=)
KR (1) KR20260018020A (https=)
CN (1) CN121218983A (https=)
TW (1) TW202513048A (https=)
WO (1) WO2024248079A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119732941B (zh) * 2024-12-30 2026-04-28 上海博悦生物科技有限公司 含有苯磺酸美洛加巴林的药物组合物及其制备方法
CN120531691B (zh) * 2025-06-20 2026-04-28 苏州美诺医药科技有限公司 一种苯磺酸美洛加巴林固体药物组合物、制剂及其制备方法
CN121221543A (zh) * 2025-11-26 2025-12-30 华润双鹤利民药业（济南）有限公司 一种苯磺酸美洛加巴林口崩片制剂及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009041453A1 (ja) 2007-09-28 2009-04-02 Daiichi Sankyo Company, Limited 二環性γ－アミノ酸誘導体
WO2014163132A1 (ja) 2013-04-04 2014-10-09 第一三共株式会社 アミノカルボン酸の塩の固形組成物
WO2016148264A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
WO2020027019A1 (ja) 2018-07-30 2020-02-06 第一三共株式会社 安定化剤を含有する医薬品の固形製剤
WO2021132072A1 (ja) 2019-12-23 2021-07-01 第一三共株式会社 滑らかな表面を有するフィルムコーティング錠
WO2022024979A1 (ja) 2020-07-27 2022-02-03 第一三共株式会社 ミロガバリンベシル酸塩を含有する口腔内崩壊錠

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009041453A1 (ja) 2007-09-28 2009-04-02 Daiichi Sankyo Company, Limited 二環性γ－アミノ酸誘導体
WO2014163132A1 (ja) 2013-04-04 2014-10-09 第一三共株式会社 アミノカルボン酸の塩の固形組成物
WO2016148264A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
WO2020027019A1 (ja) 2018-07-30 2020-02-06 第一三共株式会社 安定化剤を含有する医薬品の固形製剤
WO2021132072A1 (ja) 2019-12-23 2021-07-01 第一三共株式会社 滑らかな表面を有するフィルムコーティング錠
WO2022024979A1 (ja) 2020-07-27 2022-02-03 第一三共株式会社 ミロガバリンベシル酸塩を含有する口腔内崩壊錠

Also Published As

Publication number Publication date
WO2024248079A1 (ja) 2024-12-05
JPWO2024248079A1 (https=) 2024-12-05
TW202513048A (zh) 2025-04-01
CN121218983A (zh) 2025-12-26

Similar Documents

Publication Publication Date Title
KR20260018020A (ko) 미로가발린을 함유하는 의약 조성물
JP4832045B2 (ja) メキタジン、イブプロフェン及びトラネキサム酸含有医薬組成物
CA2861480C (en) Oral composition comprising .alpha.,.alpha.,.alpha.-trifluorothymidine (ftd), 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1h,3h)-pyrimidine dione hydrochloride (tpi)
WO2012043709A1 (ja) 難溶性薬物の溶解性改善製剤
JP6126456B2 (ja) 打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
JP2026009322A (ja) 医薬組成物
WO2016088010A1 (en) Oseltamivir compositions
WO2020027019A1 (ja) 安定化剤を含有する医薬品の固形製剤
US20180344648A1 (en) Clobazam tablet formulation and process for its preparation
CN110494139B (zh) 含有纳呋拉啡的经片剂化的药物组合物
TR202014694A1 (tr) Eltrombopag olami̇n i̇çeren bi̇r kati oral farmasöri̇k formülasyon
JP5699339B2 (ja) 徐放性製剤
JP2024067030A (ja) ミラベグロン含有放出制御医薬組成物及びその製造方法
US9775832B2 (en) Pharmaceutical composition for oral administration
JP2005314413A (ja) 経口投与用医薬組成物
JP2000336032A (ja) ピペラジンアセトアミド誘導体を含有する徐放性経口医薬品組成物
TW201808290A (zh) 經光穩定性提升之固體製劑
JP6114573B2 (ja) ロキソプロフェンナトリウムと制酸剤を含有する固形製剤
JP7206872B2 (ja) アジルサルタン及びアムロジピンを含有する医薬組成物及びその製造方法
HK40129253A (zh) 含有米洛巴林的医药组合物
JPWO2007046411A1 (ja) イソキサゾール化合物の安定化方法
JP5791817B2 (ja) 溶出性及び／又は吸収性が改善された経口投与用医薬組成物
EA045037B1 (ru) Фармацевтические составы ингибиторов индоламин-2,3-диоксигеназы
EP4599824A1 (en) A solid oral pharmaceutical formulation comprising avatrombopag
JP5899036B2 (ja) エフェドリン（塩）含有粒子及び固形製剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE)